Nutralife Biosciences Valuation
| NLBS Stock | USD 0.0001 0.00 0.00% |
Nutralife Biosciences seems to be overvalued based on Macroaxis valuation methodology. Our model forecasts the value of Nutralife Biosciences from analyzing the firm fundamentals such as Shares Outstanding of 176.62 M, return on equity of -14.26, and Operating Margin of (3.80) % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Nutralife Biosciences' price fluctuation is very steady at this time. Calculation of the real value of Nutralife Biosciences is based on 3 months time horizon. Increasing Nutralife Biosciences' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Nutralife pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Nutralife Biosciences. Since Nutralife Biosciences is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Nutralife Pink Sheet. However, Nutralife Biosciences' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.4E-5 | Hype 1.0E-4 |
The intrinsic value of Nutralife Biosciences' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Nutralife Biosciences' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Nutralife Biosciences helps investors to forecast how Nutralife pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Nutralife Biosciences more accurately as focusing exclusively on Nutralife Biosciences' fundamentals will not take into account other important factors: Nutralife Biosciences Total Value Analysis
Nutralife Biosciences is now forecasted to have valuation of 11.61 M with market capitalization of 6.62 M, debt of 10 K, and cash on hands of 51.8 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Nutralife Biosciences fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
11.61 M | 6.62 M | 10 K | 51.8 K |
Nutralife Biosciences Investor Information
About 46.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.03. Nutralife Biosciences had not issued any dividends in recent years. Based on the key indicators related to Nutralife Biosciences' liquidity, profitability, solvency, and operating efficiency, Nutralife Biosciences is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Nutralife Biosciences Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Nutralife Biosciences has an asset utilization ratio of 12.92 percent. This implies that the Company is making $0.13 for each dollar of assets. An increasing asset utilization means that Nutralife Biosciences is more efficient with each dollar of assets it utilizes for everyday operations.Nutralife Biosciences Ownership Allocation
Nutralife Biosciences maintains a total of 176.62 Million outstanding shares. Nutralife Biosciences holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Nutralife Biosciences Profitability Analysis
The company reported the previous year's revenue of 626.62 K. Net Loss for the year was (5.83 M) with profit before overhead, payroll, taxes, and interest of 83.59 K.About Nutralife Biosciences Valuation
The pink sheet valuation mechanism determines Nutralife Biosciences' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Nutralife Biosciences based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Nutralife Biosciences. We calculate exposure to Nutralife Biosciences's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Nutralife Biosciences's related companies.NutraLife BioSciences, Inc., together with its subsidiaries, engages in the development, manufacture, and distribution of nutraceutical, dietary, wellness, and cannabidiol products. NutraLife BioSciences, Inc. was incorporated in 2010 and is based in Coconut Creek, Florida. Nutralife Biosciences operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 12 people.
8 Steps to conduct Nutralife Biosciences' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Nutralife Biosciences' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Nutralife Biosciences' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Nutralife Biosciences' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Nutralife Biosciences' revenue streams: Identify Nutralife Biosciences' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Nutralife Biosciences' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Nutralife Biosciences' growth potential: Evaluate Nutralife Biosciences' management, business model, and growth potential.
- Determine Nutralife Biosciences' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Nutralife Biosciences' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Nutralife Biosciences Growth Indicators
Investing in growth stocks can be very risky. If the company such as Nutralife Biosciences does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 146.3 M | |
| Retained Earnings | -47.6 M |
Additional Tools for Nutralife Pink Sheet Analysis
When running Nutralife Biosciences' price analysis, check to measure Nutralife Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutralife Biosciences is operating at the current time. Most of Nutralife Biosciences' value examination focuses on studying past and present price action to predict the probability of Nutralife Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutralife Biosciences' price. Additionally, you may evaluate how the addition of Nutralife Biosciences to your portfolios can decrease your overall portfolio volatility.